Quick Answer
Axsome Therapeutics, Inc. reported Common Stock Shares Outstanding of 50.88 million shares for the year ending 2025.
- Axsome Therapeutics, Inc. showed an increase of +4.6% in Common Stock Shares Outstanding from 2024 to 2025.
- This data is from Axsome Therapeutics, Inc.'s annual report (Form 10-K), filed with the SEC on February 23, 2026.
- XBRL data for this metric is available from 2015 to 2025 (11 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 11 years of available data (2015 to 2025), Axsome Therapeutics, Inc.'s Common Stock Shares Outstanding has grown by 165.7%.
- Historical annual values: Fiscal year 2025: 50.88 million shares | Fiscal year 2024: 48.67 million shares | Fiscal year 2023: 47.35 million shares | Fiscal year 2022: 43.50 million shares | Fiscal year 2021: 37.82 million shares | Fiscal year 2020: 37.37 million shares | Fiscal year 2019: 36.93 million shares | Fiscal year 2018: 30.09 million shares | Fiscal year 2017: 25.49 million shares | Fiscal year 2016: 19.15 million shares | Fiscal year 2015: 19.15 million shares.
- Data sourced from SEC EDGAR public filings as of June 22, 2026.
Last verified: